These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18589718)

  • 1. [Clinical efficiency of ivabradine in patients with cardiorespiratory pathology].
    Kolomoets NM; Bakshiev VI; Zarubina EG; Usenko SV; Arkad'eva NM; Kostycheva TV; Uvaĭsova KU
    Klin Med (Mosk); 2008; 86(5):44-54. PubMed ID: 18589718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of therapy with bisoprolol and ivabradine in patients with ischemic heart disease combined with chronic obstructive pulmonary disease assessment of parameters of 24-hour ECG monitoring].
    Grigor'eva NIu
    Kardiologiia; 2009; 49(7-8):38-41. PubMed ID: 19656105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of ivabradine in patients with ischemic heart disease in combination with chronic obstructive pulmonary disease].
    Kolomoets NM; Baksheev VI; Zarubina EG
    Kardiologiia; 2008; 48(3):13-9. PubMed ID: 18429751
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the I(f) channel blocker ivabradine on the parameters of external respiration function in patients with chronic obstructive pulmonary disease in its stable course period].
    Komlev AD; Kuziaev AI; Laskin GM; Kuzenkova VE; Kolosova MV
    Ter Arkh; 2010; 82(3):23-5. PubMed ID: 20564916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy of ivabradin and nebivolol addition in combined treatment of ischemic heart disease patients with left ventricular dysfunction].
    Tatarchenko IP; Pozdniakova NV; Biriuchenko MV; Kapelovich VIu; Sekerko SA; Kupaeva RA
    Ter Arkh; 2008; 80(9):40-4. PubMed ID: 19555036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ivabradin on mechanism of inter-ventricle interaction and respiratory function in conditions of cardio-respiratory pathology (results of Russian pilot study)].
    Kolomoets NM; Baksheev VI; Kartashov VT; Zarubina EG; Arkad'eva NM; Kostycheva TV; Shvediuk VM
    Voen Med Zh; 2008 Feb; 329(2):47-53. PubMed ID: 18416113
    [No Abstract]   [Full Text] [Related]  

  • 7. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
    Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
    Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
    Amosova E; Andrejev E; Zaderey I; Rudenko U; Ceconi C; Ferrari R
    Cardiovasc Drugs Ther; 2011 Dec; 25(6):531-7. PubMed ID: 21830063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the Antianginal Efficacy of Ivabradine In Patients With Ischemic Heart Disease Complicated by Heart Failure].
    Lopatin YM;
    Kardiologiia; 2015; 55(5):5-11. PubMed ID: 26615618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
    Kolomoets NM; Baksheev VI; Uvaĭsova KU
    Klin Med (Mosk); 2008; 86(6):38-43. PubMed ID: 18720710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pediatric case of cardiomyopathy induced by inappropriate sinus tachycardia: efficacy of ivabradine.
    Romeo E; Grimaldi N; Sarubbi B; D'Alto M; Santarpia G; Scognamiglio G; Russo MG; Calabrò R
    Pediatr Cardiol; 2011 Aug; 32(6):842-5. PubMed ID: 21479666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Treatment With Ivabradine on Quality of Life of Patients With Ischemic Heart Disease: Results of the LINCOR Program].
    Glezer MG;
    Kardiologiia; 2015; 55(2):4-9. PubMed ID: 26164981
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of ivabradine in combination therapy for complicated acute coronary syndrome in patients with type 2 diabetes mellitus].
    Kondrat'ev AI; Dolgikh VT; Stotskiĭ AO
    Ter Arkh; 2010; 82(1):27-31. PubMed ID: 20364696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of ivabradine in patients with stable angina and comorbid chronic obstructive pulmonary disease].
    Khamaeva AA; Belialov FI; Kerzina LV; Berezovskaia OV; Parshukova ED; Zakharova GIu
    Kardiologiia; 2012; 52(1):15-9. PubMed ID: 22304347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ivabradin (coraxan). One more new approach to fighting myocardial ischemia in patients with ischemic heart disease].
    Eliseev OM
    Ter Arkh; 2006; 78(9):78-86. PubMed ID: 17076230
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of ivabradine on pulmonary hypertension in chronic obstructive pulmonary disease].
    Akhmetzianova ÉKh; Gaĭnitdinova VV; Bakirov AB; Bogoroditskaia OA; Timershina IR
    Kardiologiia; 2012; 52(2):41-6. PubMed ID: 22792738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical-hemodynamic and anti-ischemic effects ivabradine and nebivolol ischemic heart disease with left ventricular dysfunction].
    Abuladze GV; Kvirkveliia AA; Nebieridze MI; Chachua TB; Dundua GI
    Georgian Med News; 2010 Oct; (187):24-7. PubMed ID: 21098889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
    Fischer-Rasokat U; Honold J; Lochmann D; Wolter S; Liebetrau C; Fichtlscherer S; Möllmann H; Spyridopoulos I; Hamm CW
    Clin Res Cardiol; 2016 Jun; 105(6):527-34. PubMed ID: 26687495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
    Böhm M; Robertson M; Ford I; Borer JS; Komajda M; Kindermann I; Maack C; Lainscak M; Swedberg K; Tavazzi L
    Am J Cardiol; 2015 Dec; 116(12):1890-7. PubMed ID: 26508709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.